FDA to more aggressively tackle disruptive drug shortages
by Linda A. Johnson
This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The FDA said Thursday, July 12, 2018, it plans to more aggressively fight the persistent medication shortages that have led to rationing, disrupted hospital operations and even compromised patient care. It's a new approach for the drug regulator, which has typically waited until shortages began or were imminent to take action. (AP Photo/Andrew Harnik, File)
The U.S. Food and Drug Administration wants to more aggressively fight medication shortages that recently have led to rationing of some drugs and disrupted hospital operations.
The FDA said Thursday that it's forming a task force to find ways to improve the supply of crucial drugs. It's a new approach for the drug regulator, which has no control over companies. It generally can't act until drugmakers say shortages are imminent.
Many shortages involve low-profit generic pills and injections that are hospital workhorses, like antibiotics and painkillers. Many are made by only a few companies so when production problems occur, other drugmakers can't make up for the shortfall.
Citation:
FDA to more aggressively tackle disruptive drug shortages (2018, July 12)
retrieved 6 May 2024
from https://medicalxpress.com/news/2018-07-fda-aggressively-tackle-disruptive-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
